2CEECS
Bluelighter
Selegiline is pretty amazing stuff. I have a prescription in the form of Emsam®, a transdermal patch for Selegiline. It comes in three varieties: "20mg (6mg/24h)", "30mg (9mg/24h)", and "40mg (12mg/24h)". I used the 20mg variant for two weeks (noticing effects within 20 hours!) before moving up to the 30mg version, which I have been using for about three weeks.
I am curious for an explanation of these dosage numbers, especially in comparison to oral doses. The lowest strength is generally considered to be entirely MAO-B selective, whereas the two higher doses are suspected to cause partial MAO-A inhibition as well. (The company's literature recommends dietary restrictions for people on the stronger doses, but because of the transdermal delivery method, any partial MAO-A inhibition isn't happening in the digestive tract. There is a fair amount of support to the idea that this is unnecessary, and merely an FDA-enforced precaution due to lack of enough clinical trials proving that an MAOI doesn't pose the threat of hypertensive crisis.)
I am also interested in hearing from any other Emsam users on their interaction experiences since starting the routine. I have not yet used any of my chemicals that are metabolized by MAO, -A or -B, because I am unsure the degree of MAO-A inhibition and don't have enough information about, taking, say, a phenethylamine like 2C-E during near-complete MAO-B inhibition (sounds like something that must be done with great care, if at all).
Incidentally, I will be visiting Amsterdam soon, as I am leaving for a tour of Europe on the 9th. While there, I will definitely be evaluating the THC products--but I also want to be prepared to try the mushrooms. For that, I need a better understanding of the level of MAO-A inhibition I am under (if Psilocybin is not metabolized by MAO-A, please correct me).
Thanks!
I am curious for an explanation of these dosage numbers, especially in comparison to oral doses. The lowest strength is generally considered to be entirely MAO-B selective, whereas the two higher doses are suspected to cause partial MAO-A inhibition as well. (The company's literature recommends dietary restrictions for people on the stronger doses, but because of the transdermal delivery method, any partial MAO-A inhibition isn't happening in the digestive tract. There is a fair amount of support to the idea that this is unnecessary, and merely an FDA-enforced precaution due to lack of enough clinical trials proving that an MAOI doesn't pose the threat of hypertensive crisis.)
I am also interested in hearing from any other Emsam users on their interaction experiences since starting the routine. I have not yet used any of my chemicals that are metabolized by MAO, -A or -B, because I am unsure the degree of MAO-A inhibition and don't have enough information about, taking, say, a phenethylamine like 2C-E during near-complete MAO-B inhibition (sounds like something that must be done with great care, if at all).
Incidentally, I will be visiting Amsterdam soon, as I am leaving for a tour of Europe on the 9th. While there, I will definitely be evaluating the THC products--but I also want to be prepared to try the mushrooms. For that, I need a better understanding of the level of MAO-A inhibition I am under (if Psilocybin is not metabolized by MAO-A, please correct me).
Thanks!